Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis.

Drugs · 2015 · PMC4464731 · PMID 26033077

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

Reductions in the risk of 6-month CDP failed to reach significance in either study [ 25 ] and no significant changes in MSFC were reported in TEMSO [ 30 ].

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.